Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 3/2018

01-03-2018 | Maternal-Fetal Medicine

The impact of third-trimester genetic counseling

Authors: Reuven Sharony, Offra Engel, Shira Litz-Philipsborn, Rivka Sukenik-Halevy, Tal Biron-Shental, Mark I. Evans

Published in: Archives of Gynecology and Obstetrics | Issue 3/2018

Login to get access

Abstract

Objective

To evaluate the impact of genetic counseling (GC) during the third trimester by analyzing changes in pregnancy management and the correlation with postnatal findings.

Methods

This was a retrospective study. Pregnancy course and neonatal follow-up were analyzed according to the reason for referral and implementation of recommendations.

Results

The records of neonates born to 181 women were retrieved. Fifty-two women (group 1—29%) qualified for pregnancy termination under Israeli guidelines and laws, and 129 (group 2—71%) were not at the time they were referred. By another division: 104 women (group 3—57%) followed the physician’s diagnostic recommendations completely after counseling including amniocentesis, fetal MRI, targeted ultrasound scans, fetal echocardiography. Seventy-seven declined amniocentesis (group 4—43%). Additional abnormalities were detected postpartum in all groups without statistically difference: 3/52 (10%) in group 1, 9/129 (7%) in group 2, 6/104 (6%) in group 3, and 6/77 (8%) in group 4).

Conclusion

GC in the third trimester of pregnancy provided the couple with a sharper more focused picture and assisted them to perceive the significance of new, significant fetal findings which attest to the value of the GC.
Appendix
Available only for authorised users
Literature
1.
Monk D, Moore GE (2004) Intrauterine growth restriction—genetic causes and consequences. Semin Fetal Neonatal Med 9:371–378CrossRefPubMed
2.
Hendrix N, Berghella V (2008) Non-placental causes of intrauterine growth restriction. Semin Perinatol 32:161–165CrossRefPubMed
3.
Hall JG (2010) Review and hypothesis: syndromes with severe intrauterine growth restriction and very short stature—are they related to the epigenetic mechanism(s) of fetal survival involved in the developmental origins of adult health and disease? Am J Med Genet Part A 152A:512–527CrossRefPubMed
4.
Todros T, Massarenti I, Gaglioti P et al (2004) Fetal short femur length in the second trimester and the outcome of pregnancy. BJOG 111:83–85CrossRefPubMed
5.
Arahori H, Tamura A, Wasada K et al (2007) Sonographic femur length to trunk cross area ratio: prediction of fetal outcome in 30 cases in which micromelia was suspected. J Obstet Gynaecol Res 33:248–253CrossRefPubMed
6.
7.
8.
9.
10.
11.
Goetzinger KR, Cahill AG, Macones GA et al (2012) Isolated short femur length on second-trimester sonography: a marker for fetal growth restriction and other adverse perinatal outcomes. J Ultrasound Med 31:19CrossRef
12.
13.
14.
15.
16.
17.
Maymon E, Ghezzi F, Shoham-Vardi I et al (1998) Isolated hydramnios at term gestation and the occurrence of peripartum complications. Eur J Obstet Gynecol Reprod Biol 77:157–161CrossRefPubMed
18.
Aviram A, Salzer L, Hiersch L et al (2015) Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome. Obstet Gynecol 125:825–832CrossRefPubMed
19.
20.
21.
22.
Mercier S, Dubourg C, Belleguic M et al (2010) GC and “molecular” prenatal diagnosis of holoprosencephaly (HPE). Am J Med Genet Part C (Semin Med Genetics) 154C:191–196CrossRef
23.
Huang J, Wah IYM, Pooh RK et al (2012) Molecular genetics in fetal neurology. Semin Fetal Neonatal Med 17:341–346CrossRefPubMed
24.
25.
Woolf AS (2000) A molecular and genetic view of human renal and urinary tract malformations. Kidney Int 58:500–512CrossRefPubMed
26.
Nakanishi K, Yoshikawa N (2003) Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT). Pediatr Int 45:610–616CrossRefPubMed
27.
Deshpandea C, Hennekamb RCM (2008) Genetic syndromes and prenatally detected renal anomalies. Semin Fetal Neonatal Med 13:171–180CrossRef
28.
29.
30.
Maymon R, Sharon M, Reish O et al (2003) Fetal abnormalities leading to termination of pregnancy: the experience at the Assaf Harofeh medical center between the years 1999–2000. Harefuah 142:405–409 (in Hebrew) PubMed
31.
Vaknin Z, Ben-Ami I, Reish O et al (2006) Fetal abnormalities leading to termination of singleton pregnancy: the 7-year experience of a single medical center. Prenat Diagn 26:938–943CrossRefPubMed
32.
Dollberg S, Haklai Z, Mimouni FB et al (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7:311–314PubMed
33.
Fraser FC (1974) Genetic counseling. Am J Human Genet 26:636–661
34.
35.
Pryde PG, Odgers AE, Isada NB et al (1992) Determinants of parental decision to abort (DTA) or continue for non-aneuploid ultrasound detected abnormalities. Obstet Gynecol 80:52–56PubMed
36.
Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R (1998) Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol 76(2):141–146CrossRefPubMed
37.
Drummond CL, Gomes DM, Senat MV et al (2003) Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population. Prenat Diagn 23:1068–1072CrossRefPubMed
38.
39.
Kose S, Altunyurt S, Yıldırım N et al (2015) Termination of pregnancy for fetal abnormalities: main arguments and a decision-tree model. Prenat Diagn 35:1128–1136CrossRefPubMed
40.
41.
42.
43.
Evans MI, Wapner RJ, Berkowitz RL (2016) Non invasive prenatal screening or advanced diagnostic testing: caveat emptor. Am J Obstet Gynecol 215:298–305CrossRefPubMed
44.
Safonova I, Abdullaev R, Safonov R (2016) EP16.17: the value of ultrasound studies after 24 gestational weeks for the diagnosis of fetal pathology in low-risk pregnancy. Ultrasound Obstet Gynecol 48(Suppl 1):336–337. https://​doi.​org/​10.​1002/​uog.​17019
Metadata
Title
The impact of third-trimester genetic counseling
Authors
Reuven Sharony
Offra Engel
Shira Litz-Philipsborn
Rivka Sukenik-Halevy
Tal Biron-Shental
Mark I. Evans
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4638-8

Other articles of this Issue 3/2018

Archives of Gynecology and Obstetrics 3/2018 Go to the issue

Maternal-Fetal Medicine

Preeclampsia acts differently in in vitro fertilization versus spontaneous twins

Gynecologic Endocrinology and Reproductive Medicine

Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study

Gynecologic Oncology

Fully sialylated alpha-chain of complement 4-binding protein (A2160): a novel prognostic marker for epithelial ovarian carcinoma

Maternal-Fetal Medicine

Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis

General Gynecology

Effectiveness of celecoxib for pain relief and antipyresis in second trimester medical abortions with misoprostol: a randomized controlled trial

Review

Surgery in adenomyosis